High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

METZELDER, S. K ; SCHROEDER, T ; HEINICKE, T ; STUHLMANN, R ; MÜLLER, L ; GIAGOUNIDIS, A ; MEYER, R. G ; BRUGGER, W ; VÖHRINGER, M ; DREGER, P ; MORI, M ; BASARA, N ; FINCK, A ; SCHÄFER-ECKART, K ; SCHULTHEIS, B ; BALDUS, C ; NEUBAUER, A ; BURCHERT, A ; SCHOLL, S ; FEY, M ; GÖTZE, K ; LINN, Y. C ; KRÖGER, M ; REITER, A ; SALIH, H. R

Leukemia, 2012-11, Vol.26 (11), p.2353-2359 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível